Cutler Group LP Surface Oncology, Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	BUY	$1.42 - $3.15 $142 - $315	100 Added 8.33%	1,300 $4,000
Q1 2022 Apr 14, 2022	SELL	$2.65 - $5.08 $6,890 - $13,208	-2,600 Reduced 68.42%	1,200 $2,000
Q4 2021 Jan 18, 2022	BUY	$4.73 - $7.9 $17,974 - $30,020	3,800 New	3,800 $21,000
Q3 2021 Oct 26, 2021	SELL	$5.16 - $7.98 $516 - $798	-100 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$7.25 - $13.82 $21,750 - $41,460	-3,000 Reduced 96.77%	100 $0
Q4 2020 Jan 21, 2021	BUY	$6.87 - $10.48 $21,297 - $32,488	3,100 New	3,100 $1,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.